4.235USD+1.00%Mkt Cap: 541.75M USDP/E: —Last update: 2026-06-01
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lig…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap541.75M USD
Enterprise Value306.36M USD
Revenue (TTM)204.17M USD
Gross Profit104.46M USD
Net Income (TTM)-66.54M USD
Revenue/Share1.597 USD
Last Price4.235 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees678
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)22.05
PEG—
EV/EBITDA-8.44
EV/Revenue1.50
P/S2.65
P/B1.65
EPS (TTM)-0.58
EPS (Forward)0.19
52W Range
2.54047% of range6.180
52W High6.180 USD
52W Low2.540 USD
Profitability
Gross Margin51.84%
Oper. Margin-41.83%
EBITDA Margin-17.78%
Profit Margin-33.02%
ROE-19.47%
ROA-14.42%
Growth
Revenue Growth6.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.69M USD
CapEx (TTM)4.19M USD
FCF Margin3.14%
FCF Yield1.18%
Net Debt-234.74M USD
Net Debt/EBITDA6.47
Balance Sheet
Debt/Equity0.07
Current Ratio4.69
Quick Ratio3.94
Book Value/Sh2.537 USD
Cash/Share2.031 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.688 USD
Target Range4.750 USD – 7.500 USD
# Analysts4
Ownership
Shares Out.129.14M
Float96.62M
Insiders8.43%
Institutions67.59%
Short Interest
Short Ratio7.9d
Short % Float6.74%
Short % Out.5.32%
Shares Short6.86M
Short (prev mo.)8.10M
Technical
SMA 504.370 (-3.1%)
SMA 2004.481 (-5.5%)
Beta1.23
S&P 52W Chg27.94%
Avg Vol (30d)861.97K
Avg Vol (10d)1.13M
Technical Indicators
RSI (14)51.5
MACD-0.1126
MACD Signal-0.1609
MACD Hist.+0.0482
BB Upper5.110 USD
BB Middle4.119 USD
BB Lower3.127 USD
BB Width48.16%
ATR (14)0.2570 USD
Vol Ratio (20d)0.46x